Application 203491
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ILEVRO | NEPAFENAC | SUSPENSION/DROPS;OPHTHALMIC | 0.3% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0065-1750 | ILEVRO | nepafenac | Alcon Laboratories, Inc. | NDA | Current |
| 0065-1750 | ILEVRO | nepafenac | Alcon Laboratories, Inc. | NDA | Current |
| 0065-1750 | ILEVRO | nepafenac | Alcon Laboratories, Inc. | NDA | Current |
| 0065-1750 | ILEVRO | nepafenac | Alcon Laboratories, Inc. | NDA | Current |
| 0078-0743 | ILEVRO | nepafenac | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0743 | ILEVRO | nepafenac | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0743 | ILEVRO | nepafenac | Novartis Pharmaceuticals Corporation | NDA | Current |